Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Quality of life (QOL)
Important aspects of a patient's well-being that contribute to the physical, social and emotional condition of an individual. Quality of life should not be mistaken for the concept of standard of living, which is founded foremost on economics. The general indicators for Quality of Life are based upon, not only wealth and employment, but environment, physical and mental health, education, leisure time, and social tendencies.
See also:
Quality of life trials
Quality-adjusted life year (QALY)
Related terms
Health technology assessment/appraisal (HTA), International Clinical Trial Registry Platform (ICTRP), Healthy years equivalent (HYE), Congenital, Alternative service providers (ASP), Cost-minimisation analysis (CMA), Cost-effective (healthcare economics), Health-related Quality of QOL, Health Status Measure, Health economics, Global Health Index, Health Care prepayment plan (HCPP) (US) , Quality-adjusted life year (QALY), Cost-effectiveness threshold (health economics), Health profile,
COVID-19 Updates and Daily News
Featured jobs
- SAD/ Group Account Director, Medical Communications, Remote UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Medical Writer, MRNA/ Covid 19, Medical Communications, U...
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- FDA limits use of Janssen’s COVID-19 vaccine
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Shionogi and F2G partner to develop antifungal treatment olorofim
- Viseven and Next Pharma Partnership Announcement
- Holistic Excellence
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Biogen retracts EMA application for Alzheimer's drug Aduhelm
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Roche shares new positive Ocrevus data for MS patients
- WHO releases estimates of 14.9 million excess deaths during COVID-19 pandemic
- Patient journey mapping: exploring the clinical and the emotional journey
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
